Analysis of Runs of Homozygosity and Inbreeding
Runs of homozygosity (ROH) and inbreeding were assessed in GAL and other reference populations using WGS data analyzed in PLINK (Chang
et al., 2015). ROH segments were identified trinc previous protocols (Serra-Vidal
et al., 2019), applying sliding windows of 50 SNPs across the genome, defining segments containing a minimum of 50 SNPs within 100 kbp, allowing gaps of up to 2000 kbp between consecutive SNPs, with no more than one heterozygous site and five missing sites. To evaluate differences between GAL and other populations, Wilcoxon tests were computed on multiple ROH metrics: total counts of short and long ROH segments (
nROHS and
nROHL; respectively), cumulative length of short and long ROH segments (
sROHSand
sROHL, respectively), and average length of short and long ROH segments (
mROHS and
mROHL, respectively); here, short segments are defined as those ≤1.5 Mb and long segments as those >1.5 Mb. We also computed
FROH, which estimates the total inbreeding coefficient (estimator of FIT of Wright’s fixation index (Hartl & Clark, 2007)) and is defined as the sum of ROH segments >1.5 Mb divided by the total length of the genome in Mb (in our study, 2,795 megabases [Mb]).
We additionally computed four single-point estimators of inbreeding coefficients based on allele frequencies. The coefficient
FHET measures the average SNP homozygosity within an individual relative to the expected homozygosity of alleles randomly drawn from the population (genome-wide homozygous excess due to inbreeding).
Fhat1 represents the variance-standardized relationship minus 1 (equivalent to the diagonal of the covariance matrix used for PCA).
Fhat2is based on the homozygous excess. The estimator
FHET is analogous to the
FHAT2 estimator, both measuring the excess of homozygosity, but they are not identical; while
FHET is a ratio of sums,
FHAT2 is a sum of ratios (Gazal et al., 2014).
Fhat3 is based on the correlation between uniting gametes; it uses the initial definition of the inbreeding coefficient proposed originally by Sewall Wright in 1922. PLINK v1.9 (Chang
et al., 2015) software was used to curate the data and perform most of the analyses. R statistical software (The R Core Team, 2019) was used for the fruta of identity-of-state values used in the MDS analysis, ROH, and F inbreeding metrics, and graphic representations.
Exploring Variants of Biomedical Interest
We are interested in exploring genomic variation in Galicia on a WGS scale, particularly its biomedical relevance compared to the broader Iberian population. This could help anticipate the potential benefits of conducting large-scale whole-genome projects at a regional level, rather than focusing solely on, e.g. exome variation, which, while more cost-effective, may not capture the full spectrum of relevant genetic diversity.
First, we conducted a single-point allele association test, comparing single-nucleotide polymorphism (SNP) variants detected in GAL with those in IBS (
n = 107) and a merged European dataset (CEU + GBR + IBS + TSI;
n = 404). This approach mimics a GWA’s study, where typically a cohort of cases (such as GAL) is compared to a cohort of controls (such as IBS) (Salas
et al., 2017). For this analysis, we included only variants with a minor allele frequency (MAF) above 0.05 in cases and controls and a Hardy-Weinberg equilibrium
P-value > 0.001 for GAL, IBS, and the European merged dataset.
Second, to investigate the impact of accumulated pathogenic variants in genes that could increase susceptibility to common diseases in Galicia compared to other Iberian/European populations, we performed a statistical association test using the collapsing method known as the Optimized Sequence Kernel Association Test (SKAT-O) (Lee
et al., 2012). This method combines a set of generalized SKAT tests with varying proportions of SKAT and Burden. We incorporated annotated information for each variant obtained from the Combined Annotation Dependent Depletion (CADD) v1.6. database (Rentzsch
et al., 2021). We undertook this gene-based statistical analysis using the
SKAT R library (Lee & Miropolsky, 2023) and considering all variants within genes, aiming to capture rare variations that could be of biomedical interest and might go unnoticed in single-point association tests. Genes with at least two variants were considered for these analyses. A nominal significance level was set to 0.05. To monitor multiple tests, we used the Bonferroni correction.
The top SNP and gene candidates from these analyses were further investigated for their association with medical conditions. For this, we gathered information from SNPedia, (downloaded from Category:Is a snp - SNPedia [for SNP variation] and Category:Is a gene - SNPedia [for genes], updated in October 2023) and classified it into ten macro-areas (October 2024). The SNPedia contains information on 111,702 genetic variants and 2,164 genes (SNPedia:FAQ - SNPedia Pedia.3F).
Third, given the growing interest in predicting genetic predisposition to diseases and traits within the biomedical community, we analyzed potential regional differences in Polygenic Risk Score (PRS) predictions, comparing PRS values between the GAL and IBS populations. PRSs estimate disease risk based on the cumulative effect of multiple genetic variants, typically inferred from large-scale GWAs. To streamline our analysis, we selected PRSs for common diseases with significant public health relevance, including five genome-wide PRSs from Khera et al. (2018):
i) Coronary Artery Disease (PRSCAD; PGS000013): 6,630,150 polymorphisms; 6,476,712 retained after merging GAL and IBS;
ii) Atrial Fibrillation (PRSAF; PGS000016): 6,730,541 polymorphisms; 6,562,700 retained;
iii) Type 2 Diabetes (PRST2D; PGS000014): 6,917,436 polymorphisms; 6,715,496 retained;
iv) Inflammatory Bowel Disease (PRSIBD; PGS000017): 6,907,112 polymorphisms; 6,712,364 retained; and
v) Breast Cancer (PRSBC1; PGS000015): 5,218 polymorphisms; 4,532 retained. Additionally, we included:
i) a second Breast Cancer PRS metric (PRSBC2; PGS000004), implemented in the CanRisk calculator
🙂 313 polymorphisms, 286 retained;
ii) Ovarian Cancer (PRSOCAC; PGS003394): 36 polymorphisms; 36 retained (Lee
et al., 2019), also implemented in CanRisk,
iii) Acute Lower Respiratory Infection (PRSALRI; PGS000925): 402 polymorphisms, 346 retained; the only infectious disease PRS indexed in the PGS Catalog to date, included due to various EWAS carried out on infectious diseases in the Galician population to date (Camino-Mera
et al., 2024; Pardo-Seco
et al., 2024; Salas
et al., 2018), iv) Schizophrenia (PRSSCH; PGS000133): 604,645; 602,522 retained (Zheutlin
et al., 2019),
v) Autism Spectrum Disorder (PRSASD; PGS000327): 35,087 polymorphisms; 34,362 retained (Grove
et al., 2019), and Alzheimer’s Disease (PRSALZ; PGS004146): 915,771 polymorphisms; 914,409 retained (Monti
et al., 2024). This selection allows for the exploration of PRSs composed of a wide range of polymorphisms, from a few dozen to several million, capturing different levels of genome-wide architectures. Notably, ∼98% of the variants included in these PRSs are in non-coding regions of the genome, which would not be detected in EWS studies. While these non-coding variants do not alter protein sequences, they can influence gene expression and contribute to disease susceptibility. PRS calculations were performed using PLINK (Chang
et al., 2015), and values were standardized to a unit standard deviation (SD) within the GAL + IBS pooled dataset.
In addition, we have developed a web tool () that enables users to search for specific variants in the GALOMICS whole genome database, which contains information on over 18 million biallelic variants. In the “Search” tab, users can query genetic variants by two main criteria: by rsID (e.g., rs1805005) or by a combination of chromosome and position (e.g., 16: 89919436). The trinc visualizations are provided:
i) A geometric map displaying the coordinates of the samples, including layers for individuals as well as their parents and grandparents.,
ii) Various charts indicating the samples in GAL that carry the reference allele
vs. those with the alternative allele, showing the genotypic composition of individuals,
iii) A representation of allele variant frequencies across different populations worldwide, and
iv) Biomedical data of interest. For graphical representations of allele frequencies, data is sourced from external databases, including:
i) Ensembl (); Entrez: ClinGen: Allele Registry? caid=; UniProtKB: UniProt; OMIM: Home - OMIM - NCBI; dbSNP: Home - SNP - NCBI. The data obtained from these sources is structured in JSON format. Additionally, a ClinVar Data Table displays the identifiers assigned to the queried variant by ClinGen, UniProtKB, OMIM, and dbSNP. The table includes details such as the cDNA Change (alteration at the complementary DNA level), the variant’s position in the hg38 version of the human genome, the associated Trait Name, the Trait Reference, and the Protein Change (protein alterations caused by the variant).
Visualization of Genetic Data in Geographic Maps
To visualize the biogeographical distribution of genetic cluster frequencies, we first calculated individual cluster frequencies at each sampling location. These frequencies were then spatially represented on geographic maps using SAGA v. 9.6.1 (SAGA - System for Automated Geoscientific Analyses) (Conrad
et al., 2015) and the ordinary Kriging interpolation method. For the GAL samples, we had detailed information on the specific birthplaces of donors and their grandparents. In contrast, for the NDNAB samples, data resolution was limited to the provincial level. Therefore, for practical purposes, each data point was assigned to the capital city of the corresponding province. Consequently, each point in this case represents all individuals from that province, sharing the same geographic coordinates.